Authors : Nawal B.Yazea; Dhuha M. Abbas; Rand Moshtaq Talib

Volume/Issue : Volume 10 - 2025, Issue 5 - May

---

Google Scholar : https://tinyurl.com/yb4tfxr8

DOI : https://doi.org/10.38124/ijisrt/25may343

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

---

Abstract : The common Gram-negative pathogenic bacterium Acinetobacter baumannii is can result in severe illnesses and is resistant to a variety of drugs.. Women who are of childbearing age are affected by polycystic ovary syndrome, which can present with a variety of symptoms. Insulin resistance is a result of hormonal and metabolic issues that affect women and can develop to type 2 diabetes. Since individuals with diabetes or insulin resistance are known to have compromised immune systems, the body becomes an ideal habitat for a variety of microorganisms, including Acinetobacter baumannii. Objective of this review is to demonstrate the antibiotic resistance of acinetobacter baumannii with polycystic ovary syndrome

Keywords : Acinetobacter baumannii, Polycystic Ovary Syndrome, Insulin Resistance, Diabetes Mellitus.

References :

1. Kareem SM, Al-Alak SK, Khazaal SS, Najim SY, Aziz SN. Genetic detection of acinetobacter multidrug resistant isolates toward aminoglycoside and study the resistant to rifampicin/aminoglycoside combination. J Pharm Sci Res. 2018;10(6):1319–22.
2. Shi J, Cheng J, Liu S, Zhu Y, Zhu M. Acinetobacter baumannii: an evolving and cunning opponent. Front Microbiol. 2024;15:1332108.
3. Al-Kadmy IMS, Ali ANM, Salman IMA, Khazaal SS. Molecular characterization of Acinetobacter baumannii isolated from Iraqi hospital environment. New microbes new Infect. 2018;21:51–7.
4. Marino A, Augello E, Stracquadanio S, Bellanca CM, Cosentino F, Spampinato S, et al. Unveiling the Secrets of Acinetobacter baumannii: Resistance, Current Treatments, and Future Innovations. Int J Mol Sci. 2024;25(13):6814.
5. Shaheed HS, Jasim SY, Abbass WA-K. Studying some novel biochemical and immunological markers in a sample of Iraqi women with polycystic ovarian syndrome. Res J Pharm Technol. 2020;13(7):3171–8.
6. Deswal R, Narwal V, Dang A, Pundir CS. The prevalence of polycystic ovary syndrome: a brief systematic review. J Hum Reprod Sci. 2020;13(4):261–71.
7. Yang R, Li Q, Zhou Z, Qian W, Zhang J, Wu Z, et al. Changes in the prevalence of polycystic ovary syndrome in China over the past decade. Lancet Reg Heal Pacific. 2022;25.
8. Khalilov R, Abdullayeva S. MECHANISMS OF INSULIN ACTION AND INSULIN RESISTANCE. Adv Biol Earth Sci. 2023;8(2).
9. Perreault L, Newsom SA, Strauss A, Kerege A, Kahn DE, Harrison KA, et al. Intracellular localization of diacylglycerols and sphingolipids influences insulin sensitivity and mitochondrial function in human skeletal muscle. JCI insight. 2018;3(3).
10. Singh S, Pal N, Shubham S, Sarma DK, Verma V, Marotta F, et al. Polycystic ovary syndrome: etiology, current management, and future therapeutics. J Clin Med. 2023;12(4):1454.
11. Dunaif A, Segal KR, Futterweit W, Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes. 1989;38(9):1165–74.
12. Nizar L, AL-Rekabi ANG. Hormonal Study of the different phenotypes of polycystic ovary syndrome. J Coll Basic Educ. 2016;22(93):101–8.
13. Barber TM, Wass JAH, McCarthy MI, Franks S. Metabolic characteristics of women with polycystic ovaries and oligo‐amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome. Clin Endocrinol (Oxf). 2007;66(4):513–7.
14. Harrison CL, Lombard CB, Moran LJ, Teede HJ. Exercise therapy in polycystic ovary syndrome: a systematic review. Hum Reprod Update. 2011;17(2):171–83.
15. Li M, Chi X, Wang Y, Setrerrahmane S, Xie W, Xu H. Trends in insulin resistance: insights into mechanisms and therapeutic strategy. Signal Transduct Target Ther. 2022;7(1):216.
16. Wu H, Ballantyne CM. Metabolic inflammation and insulin resistance in obesity. Circ Res. 2020;126(11):1549–64.
17. Van der Kolk BW, Kalafati M, Adriaens M, Van Greevenbroek MMJ, Vogelzangs N, Saris WHM, et al. Subcutaneous adipose tissue and systemic inflammation are associated with peripheral but not hepatic insulin resistance in humans. Diabetes. 2019;68(12):2247–58.
18. Trouwborst I, Wouters K, Jocken JW, Jardon KM, Gijbels A, Dagnelie PC, et al. Circulating and adipose tissue immune cells in tissue‐specific insulin resistance in humans with overweight and obesity. Obesity. 2023;31(5):1326–37.
19. Sethi JK, Hotamisligil GS. Metabolic messengers: tumour necrosis factor. Nat Metab. 2021;3(10):1302–12.
20. Chapman NM, Chi H. Metabolic adaptation of lymphocytes in immunity and disease. Immunity. 2022;55(1):14–30.
21. Friedrich K, Sommer M, Strobel S, Thrum S, Blüher M, Wagner U, et al. Perturbation of the monocyte compartment in human obesity. Front Immunol. 2019;10:1874.
22. Krinninger P, Ensenauer R, Ehlers K, Rauh K, Stoll J, Krauss-Etschmann S, et al. Peripheral monocytes of obese women display increased chemokine receptor expression and migration capacity. J Clin Endocrinol Metab. 2014;99(7):2500–9.
23. Devêvre EF, Renovato-Martins M, Clément K, Sautes-Fridman C, Cremer I, Poitou C. Profiling of the three circulating monocyte subpopulations in human obesity. J Immunol. 2015;194(8):3917–23.
24. Crommen S, Simon M-C. Microbial regulation of glucose metabolism and insulin resistance. Genes (Basel). 2017;9(1):10.
25. Perera D, Kleinstein SE, Hanson B, Hasturk H, Eveloff R, Freire M, et al. Impaired host response and the presence of Acinetobacter baumannii in the serum microbiome of type-II diabetic patients. Iscience. 2021;24(1).
26. Darwitz BP, Genito CJ, Thurlow LR. Triple threat: how diabetes results in worsened bacterial infections. Infect Immun. 2024;e00509-23.
27. Leung C-H, Liu C-P. Diabetic status and the relationship of blood glucose to mortality in adults with carbapenem-resistant Acinetobacter baumannii complex bacteremia. J Microbiol Immunol Infect. 2019;52(4):654–62.
28. Bharadwaj A, Rastogi A, Pandey S, Gupta S, Sohal JS. Multidrug-Resistant Bacteria: Their Mechanism of Action and Prophylaxis. BioMed Research International, 2022, 17. 2022;
29. Matta-Gutierrez G, Garcia-Morales E, Garcia-Alvarez Y, Álvaro-Afonso FJ, Molines-Barroso RJ, Lazaro-Martinez JL. The influence of multidrug-resistant bacteria on clinical outcomes of diabetic foot ulcers: a systematic review. J Clin Med. 2021;10(9):1948.
30. Adeyemo AT, Kolawole B, Rotimi VO, Aboderin AO. Multicentre study of the burden of multidrug-resistant bacteria in the aetiology of infected diabetic foot ulcers. Afr J Lab Med. 2021;10(1):1–10.
31. Hodgson K, Morris J, Bridson T, Govan B, Rush C, Ketheesan N. Immunological mechanisms contributing to the double burden of diabetes and intracellular bacterial infections. Immunology. 2015;144(2):171–85.
32. Szukiewicz D. Molecular mechanisms for the vicious cycle between insulin resistance and the inflammatory response in obesity. Int J Mol Sci. 2023;24(12):9818.
33. Boucher J, Kleinridders A, Kahn CR. Insulin receptor signaling in normal and insulin-resistant states. Cold Spring Harb Perspect Biol. 2014;6(1):a009191.
34. Van Niekerk G, Christowitz C, Conradie D, Engelbrecht A-M. Insulin as an immunomodulatory hormone. Cytokine Growth Factor Rev. 2020;52:34–44.
35. Zhao X, An X, Yang C, Sun W, Ji H, Lian F. The crucial role and mechanism of insulin resistance in metabolic disease. Front Endocrinol (Lausanne). 2023;14:1149239.
36. Exley MA, Hand L, O’Shea D, Lynch L. Interplay between the immune system and adipose tissue in obesity. J Endocrinol. 2014;223(2):R41–8.
37. Villarreal-Calderón JR, Cuéllar RX, Ramos-González MR, Rubio-Infante N, Castillo EC, Elizondo-Montemayor L, et al. Interplay between the adaptive immune system and insulin resistance in weight loss induced by bariatric surgery. Oxid Med Cell Longev. 2019;2019(1):3940739.
38. Bensussen A, Torres-Magallanes JA, Roces de Álvarez-Buylla E. Molecular tracking of insulin resistance and inflammation development on visceral adipose tissue. Front Immunol. 2023;14:1014778.
39. Furniss D, Gore S, Azadian B, Myers SR. Acinetobacter infection is associated with acquired glucose intolerance in burn patients. J Burn Care Rehabil. 2005;26(5):405–8.
40. Zhao H, Zhang J, Cheng X, Nie X, He B. Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment. J Ovarian Res. 2023;16(1):9.
41. Dumesic DA, Oberfield SE, Stener-Victorin E, Marshall JC, Laven JS, Legro RS. Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome. Endocr Rev. 2015;36(5):487–525.
42. Azziz R, Carmina E, Chen Z, Dunaif A, Laven JSE, Legro RS, et al. Polycystic ovary syndrome. Nat Rev Dis Prim. 2016;2(1):1–18.
43. Hong X, Qin P, Huang K, Ding X, Ma J, Xuan Y, et al. Association between polycystic ovary syndrome and the vaginal microbiome: a case‐control study. Clin Endocrinol (Oxf). 2020;93(1):52–60.
44. Marquardt RM, Kim TH, Shin J-H, Jeong J-W. Progesterone and estrogen signaling in the endometrium: what goes wrong in endometriosis? Int J Mol Sci. 2019;20(15):3822.